Skip to content

PharmaEssentia Price, Chart & Factor Exposure

Free Data & Analytics Access

Latest earnings: November 9, 2026 results vs estimates

PharmaEssentia · E.6446.TW · Taiwan
Use symbol E.6446.TW in our API & Excel add-in to retrieve this data ↓
1,190.00
(-0.04%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 0%
Trend 50%
Bubble Risk LOW
Realised Volatility (20D) 40.68%

PharmaEssentia Forecast

PharmaEssentia short-term momentum is neutral (up over 2 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term NEUTRAL signal. The long-term trend is positive (6 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 40.7% a year, a typical one-standard-deviation range is 1,122–1,258 over a week, 1,050–1,330 over a month and 705.92–1,674 over a year. (Signals as of 1 Nov 2026.)

PharmaEssentia Price Chart

MacroFinance.ai

PharmaEssentia Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
PharmaEssentia
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
PharmaEssentia
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
PharmaEssentia
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
PharmaEssentia
P/E
54.12x
Mid-range vs own history
QoQ −28.6%
YoY +50.0%
now 54.117936.37 low83.62 high
ⓘP/E As of 22 Nov 2026.See PharmaEssentia returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
PharmaEssentia
P/S
19.96x
Mid-range vs own history
QoQ −28.4%
YoY +59.0%
now 19.958911.74 low30.74 high
ⓘP/S As of 22 Nov 2026.See PharmaEssentia returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
PharmaEssentia
P/B
12.01x
Mid-range vs own history
QoQ −23.5%
YoY +106.0%
now 12.00695.74 low17.33 high
ⓘP/B As of 22 Nov 2026.See PharmaEssentia returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
PharmaEssentia
EV/EBITDA
41.35x
Mid-range vs own history
QoQ −30.1%
YoY +14.8%
now 41.354929.88 low65.53 high
ⓘEV/EBITDA As of 22 Nov 2026.See PharmaEssentia returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
PharmaEssentia
EV/Sales
18.92x
Mid-range vs own history
QoQ −29.2%
YoY +71.2%
now 18.916610.34 low29.61 high
ⓘEV/Sales As of 22 Nov 2026.See PharmaEssentia returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
PharmaEssentia
FCF Yield
1.4%
Mid-range vs own history
QoQ +36.1%
YoY −18.3%
now 1.39810.86 low1.83 high
ⓘFCF Yield As of 22 Nov 2026.See PharmaEssentia returns when FCF Yield looked like now →Opens Return analysis with the filter FCF Yield within ±5% of today
PharmaEssentia
Earnings Yield
1.8%
Mid-range vs own history
QoQ +40.0%
YoY −33.3%
now 1.84781.2 low2.75 high
ⓘEarnings Yield As of 22 Nov 2026.See PharmaEssentia returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
PharmaEssentia
Market Cap
$491.3B
Highest in 5 years
QoQ −15.0%
YoY +183.4%
now 491346.24181,362 low637,952 high
ⓘMarket Cap As of 22 Nov 2026.See PharmaEssentia returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
PharmaEssentia
Net Debt
-$25.7B
Low vs own history
QoQ +9.4%
YoY +23.9%
now -25658.884-25,659 low-20,711 high
ⓘNet Debt As of 22 Nov 2026.See PharmaEssentia returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
PharmaEssentia
Net Debt / EBITDA
-2.28x
High vs own history
QoQ −8.9%
YoY −53.4%
now -2.2786-4.89 low-2.28 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See PharmaEssentia returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
PharmaEssentia
Current Ratio
5.00x
Mid-range vs own history
QoQ −5.3%
YoY −26.8%
now 5.00045 low6.83 high
ⓘCurrent Ratio As of 22 Nov 2026.See PharmaEssentia returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
PharmaEssentia
Quick Ratio
4.76x
Mid-range vs own history
QoQ −6.2%
YoY −27.2%
now 4.75744.76 low6.54 high
ⓘQuick Ratio As of 22 Nov 2026.See PharmaEssentia returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
PharmaEssentia
Interest Coverage
431.48x
Strong vs own history
QoQ +6.1%
YoY +181.0%
now 431.4838153.55 low431.48 high
ⓘInterest Coverage As of 22 Nov 2026.See PharmaEssentia returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
PharmaEssentia
Debt / Equity
0.03x
Low vs own history
QoQ −2.7%
YoY −10.1%
now 0.0270.03 low0.03 high
ⓘDebt / Equity As of 22 Nov 2026.See PharmaEssentia returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
PharmaEssentia
Piotroski F-Score
7
Strong vs own history
QoQ 0.0%
YoY +16.7%
now 76 low7 high
ⓘPiotroski F-Score As of 22 Nov 2026.See PharmaEssentia returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
PharmaEssentia
Altman Z-Score
38.09
Mid-range vs own history
QoQ −23.5%
YoY +59.2%
now 38.086522.16 low54.69 high
ⓘAltman Z-Score As of 22 Nov 2026.See PharmaEssentia returns when Altman Z-Score looked like now →Opens Return analysis with the filter Altman Z-Score within ±5% of today
  18 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  16 members-only factors: Sloan Accruals, Cash-Earnings Gap, Beneish M-Score, Days Sales in Receivables Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for PharmaEssentia, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

PharmaEssentia fundamentals: income statement, balance sheet & cash flow

PharmaEssentia reported revenue of 15.63bn TWD and net income of 5.05bn TWD in FY2025, the year ended 30 September 2025 — revenue up 60.6% and net income up 70.1% on the prior year. Free cash flow was 3.37bn TWD. These figures are as reported in the filings, not restated: 16 fiscal years and 53 quarters of history, back to September 2010.

Revenue (FY2025)
15.63bn TWD
+60.6%
Net income
5.05bn TWD
+70.1%
Gross margin
87.47%
Free cash flow
3.37bn TWD
+105.2%
Net debt
-21.86bn TWD
PharmaEssentia income statement, annual, as reported · TWD billions unless stated
TWD billionsFY2025FY2024FY2023FY2022FY2021
Period end30 Sep 202530 Sep 202430 Sep 202330 Sep 202230 Sep 2021
Revenue15.639.735.112.880.66
Cost of revenue1.961.180.610.810.38
Gross profit13.688.564.502.070.28
Research & development3.462.592.221.431.27
Selling, general & admin.—4.234.182.671.83
Operating income4.931.74-1.91-2.03-2.82
EBITDA5.413.38-0.67-1.60-2.57
Interest expense0.030.020.050.020.01
Pre-tax income4.982.99-0.99-1.84-2.81
Income tax-0.060.03-0.36-0.47—
Net income5.052.97-0.62-1.37-2.81

Download PharmaEssentia fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.6446.TW&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 16 fiscal years and 53 quarters, the filing vintages behind each number and API access.
Create free account

Figures in TWD, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on PharmaEssentia

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

PharmaEssentia Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to PharmaEssentia; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How PharmaEssentia’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how PharmaEssentia behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About PharmaEssentia (Taiwan)

PharmaEssentia is a listed security in Taiwan. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is PharmaEssentia?
PharmaEssentia is a listed security in Taiwan. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest PharmaEssentia price?
The latest close is 1,190 (1 Nov 2026), -0.04% on the day. The price at the top of the page refreshes during the trading day.
Is PharmaEssentia in an uptrend?
As of 1 Nov 2026, short-term momentum is neutral (2 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is positive (6 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is PharmaEssentia?
20-day realised volatility is 40.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 11.7% over a month and 5.7% over a week.
What factors affect PharmaEssentia?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to PharmaEssentia, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade PharmaEssentia?
28 backtested tactical asset allocation strategies trade PharmaEssentia through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are PharmaEssentia returns analysed?
The Statistical Distribution of Returns section shows the distribution of PharmaEssentia daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free PharmaEssentia historical data?
In the Free historical data section of this page: the last 10 years of PharmaEssentia daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free PharmaEssentia historical data (last 10 years)

Browse or instantly download the last 10 years of PharmaEssentia daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.6446.TW&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-191205
2026-11-181245
2026-11-171280
2026-11-161295
2026-11-131380
2026-11-121365
2026-11-111335
2026-11-101280
2026-11-091370
2026-11-061270
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

PharmaEssentia Corporation, a biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan. Its products include BESREMi, an interferon therapy indicated for polycythemia vera, essential thrombocythemia, PMF, and adult T-cell leukemias. The company also develops Ropeg + anti PD-1; PEG-IL-2 (P11838); PEG-Cytokines; PD-1-IL-2v; ADC; ADCS; NY-ESO-1 TCR-T; and Novel TCR-T for the treatment of solid tumor and immunology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.